BioSpace News Archive

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced it has enrolled the first patient into its AEROSURF® phase 2b bridging study in premature inf

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it will report first quarter 2020 financial results and provide a corporate update before market open on Wednesday, May 6, 2020. Jounce Therapeutics’ management team will host a live conference call and webcast at 8:00 a.m. ET. Conference Call and Webcas

The Potential for Superior and Rapid Onset Protection from Infection with Plinabulin-G-CSF Combination Marks First Significant Enhancement in Preventing Neutropenia in 30 Years

Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines, today announced that the company will present preclinical data from its oncology pipeline of Red Cell Therapeutics™ (RCTs) at the American Society of Gene and Cell Therapy (ASGCT) 23 rd Annual Meeting. The meeting is being held virtually from May 12 – 15, 2

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, will report results for its first quarter 2020 on Wednesday, May 6, 2020. Management will host a conference call to review the results at 8:30 AM ET on the same day. The conference call may be accessed by dialing (877) 312-7507 from the U.S. and Canada or (631) 813-4828 from international locat

End of Phase 2 FDA meeting scheduled to discuss the path forward for IFX-1 in Hidradenitis Suppurativa Initial promising results reported in Pyoderma Gangraenosum Part 1 of adaptive randomized trial in severe COVID-19 pneumonia fully enrolled Executed clinical collaboration agreement in oncology with Merck & Co, Inc., Kenilworth, NJ, USA (known as MSD outside the US and Canada) Senior executives hired for key positions Cash, cash equivalents and financial assets were €115.8 million as o

Sensorion a pioneering clinical-stage biotech company that specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that its Board of Directors has approved the procedure for holding this year’s General Assembly behind closed doors on Wednesday, May 20, 2020.

Transparency Market Research has published a new report titled, “Radiation Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Transparency Market Research has published a new report titled ‘Medical Lifting Slings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.’ According to the report, the global medical lifting slings market was valued at US$ 520.0 Mn in 2018.

AVITA Medical Limited, a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial results for the fiscal third quarter ended 31 March 2020 in its Appendix 4C - Quarterly Cash Flow Report filed with the Australian Securities Exchange.